| Literature DB >> 34975737 |
Peter Waweru1, Samwel Maina Gatimu2.
Abstract
Background: Stroke is a leading cause of death and disability in sub-Saharan Africa with increasing incidence. In Kenya, it is a neglected condition with a paucity of evidence despite its need for urgent care and hefty economic burden. Therefore, we reviewed studies on stroke epidemiology, care, and outcomes in Kenya to highlight existing evidence and gaps on stroke in Kenya.Entities:
Keywords: Africa; East Africa; Kenya; stroke; sub-Saharan Africa
Year: 2021 PMID: 34975737 PMCID: PMC8716633 DOI: 10.3389/fneur.2021.785607
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Characteristics of included studies.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oduor et al. ( | Stroke types, risk factors, quality of care and outcomes at a Referral Hospital in Western, Kenya | 2015 | 2010–2014 | Retrospective | Urban/Public | All strokes, ≥18 years | WHO definition of stroke | 100 | 155 | 61 (49–72) | >69 | 58 | 52 |
| Kaduka et al. ( | Stroke distribution patterns and characteristics in Kenya's leading public health tertiary institutions: Kenyatta National Hospital and Moi Teaching and Referral Hospital | 2018 | 2015–2016 | Prospective | Urban/Public | All strokes, ≥18 years | CT/MRI confirmed stroke | 100 | 691 | 60 (45-73) * | 60–69 | 57.5 | 44.4 |
| Kaduka et al. ( | Stroke mortality in Kenya's Public Tertiary Hospitals: a prospective facility-based study | 2018 | 2015–2016 | Prospective | Urban/Public | All strokes, ≥18 years | CT/MRI confirmed stroke | 100 | 719 | 58.6 (18.7) | 60–69 | 56.7 | 43.9 |
| Kaduka et al. ( | Disability-adjusted life-years due to stroke in Kenya | 2019 | 2015–2016 | Prospective | Urban/Public | All strokes, ≥18 years | CT/MR confirmed stroke | 100 | 719 | 58.6 (18.7) | 60–64 | 56.7 | 43.9 |
| Ominde et al. ( | Pattern of stroke in a rural Kenyan hospital | 2019 | 2015–2016 | Prospective | Rural/Public | All strokes, Adults | WHO definition of stroke | 100 | 227 | 68.8 (6.8) | 60–69 | 62 | 32.6 |
| Jowi et al. ( | Pathological sub-types, risk factors and outcome of stroke at the Nairobi Hospital, Kenya | 2009 | 2003–2006 | Retrospective | Urban/ Private | All strokes, ≥18 years | WHO definition of stroke | 100 | 80 | 61.3 | – | 46.2 | 8.8 |
| Muli et al. | Quality of life amongst young adults with stroke living in Kenya | 2013 | 2007–2008 | Retrospective | Urban/ Public | 15–49 years | Not defined | – | 161 | – | 40–49 | 55.9 | – |
| Ogengo and Olabu ( | Ischemic cortical stroke in a Kenyan Referral Hospital | 2015 | 2007–2011 | Retrospective | Urban/ Public | Cortical, ischemic strokes, ≥18 years | Paralysis, aphasia, and headache combined with CT scan and angiographic findings. | 100 | 377 | 54.72 (16.8) | – | 54.6 | – |
| Ogolla and Opemo ( | Early mobilization and physical activity improve stroke recovery: a cohort study of stroke inpatients in Kisumu County Referral Hospitals, Kenya | 2016 | 2015 | Prospective | Urban | All strokes, ≥18 years | Not defined | – | 100 | 59.1 (2.3) | – | 61 | – |
| Wanjiru Kingau ( | Care process for stroke patients in Kenya: mixed study | 2018 | 2014 | Retrospective | Urban–Rural/ | All strokes, Adults | Not defined | – | 150 | 61.7 (16.7) | – | 36.5 | – |
| Wairoto et al. ( | Prevalence and nature of psychiatric morbidity in stroke outpatients in Kenyatta national hospital, Kenya | 2020 | 2015 | Prospective | Urban | All strokes, ≥18 years | Not defined | – | 210 | – | – | 41 | – |
| Waweru and Gatimu ( | Mortality and functional outcomes after a spontaneous subarachnoid hemorrhage: A retrospective multicenter cross-sectional study in Kenya | 2019 | 2009–2017 | Retrospective | Urban | SAH, ≥18 years | Suggestive presentation supported by computed tomography, lumbar puncture, or necropsy evidence of SAH | 100 | 158 | 48.6 (15.9) | – | 57.6 | All |
HS, haemorrhagic stroke; SAH, subarachnoid hemorrhage.
Median (IQR);
Range.
Figure 1PRISMA flow chart of selected studies.
Risk factors and outcomes of stroke in Kenya.
|
|
|
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
| Jowi and Mativo ( | 80 | 80 | 32.5 | – | – | – | 36.5 | 2.5 | 5 | – | – | – | – | – |
| Kaduka et al. ( | 691 | 77.3 | 14.9 | 16.1 | 15.4 | 2.8 | 8 | 16.4 | 23.4 | 29.8 | 32 | |||
| Ominde et al. ( | 227 | 74 | 32 | 48 | 63 | 20 | – | 12 | – | – | – | – | – | – |
| Oduor et al. ( | 155 | 73 | 4 | 9 | 24 | 15 | 84 | 10 | 27 | – | – | – | – | – |
| Kaduka et al. ( | 719 | – | – | – | – | – | – | – | 21.6 | 18.4 | 26.7 | 34.1 | 37.8 | 41.7 |
| Waweru and Gatimu ( | 158 | 50 | – | 14.2 | 25.4 | – | – | – | 24.1 | – | 26.6 | – | – | – |
LDL ≥ 3.36 ml/l;
HDL-C <1.3 mmol/l; triglycerides > 2.2 mmol/l; total cholesterol > 6.2 mmol/l; low-density lipoprotein cholesterol > 4.1 mmol/l, or specific treatment for hypercholesterolemia.
Elevated plasma total cholesterol levels of >5.18 mmol/l or LDL cholesterol levels >2.6 mmol/l or HDL levels <1.3 mmol/l, or had been using lipid-lowering medication.
Percentage of patients lost to follow-up in brackets; HTN, hypertension; DM, diabetes mellitus.